Innovative Lung Cancer Radiation Therapy Protocol Unveiled at ASTRO

Experts from the Roswell Park Comprehensive Cancer Center will present groundbreaking findings on a new radiation therapy protocol for lung cancer at the American Society for Radiation Oncology (ASTRO) Annual Meeting, taking place from September 27 to October 1, 2025, in San Francisco. The study introduces a novel approach that utilizes a precise, high dose of radiation therapy, specifically designed for patients with non-small cell lung cancer (NSCLC) following surgical procedures.

The oral abstract presentation will be led by Mark Farrugia, MD, PhD, Clinical Assistant Professor of Oncology in Roswell Park’s Department of Radiation Medicine. This presentation is part of the prestigious Science Highlights Session, which showcases top-rated abstracts from the conference. The study, titled “A Feasibility and Toxicity Analysis of Single-Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer,” is authored by Anurag Singh, MD, Professor of Oncology and Director of Radiation Research at Roswell Park.

Presentation Details and Additional Studies

The findings from this clinical trial will be presented during two key sessions. The Science Highlights Session is scheduled for Sunday, September 28, from 8:00 to 8:30 a.m. PT, in room 160. The oral presentation will follow on Monday, September 29, from 5:40 to 5:50 p.m. PT, in room 155/157.

In addition to Dr. Farrugia’s presentation, two other significant studies from Roswell Park will be featured on Monday, September 29. Neil Almeida, MD, a Resident Physician in Roswell Park’s Department of Radiation Medicine, will present research on the early initiation of radiation therapy and its impact on survival rates in elderly patients with glioblastoma. This presentation, titled “Early Initiation of Radiation Therapy Improves Survival in Elderly Patients with Glioblastoma,” will take place from 8:00 to 9:00 a.m. PT in Hall F.

Furthermore, Dheerendra Prasad, MD, MCh, FACRO, a Professor of Radiation Medicine, will discuss the association of the Systemic Inflammation Response Index with outcomes for patients with head and neck cancer receiving definitive chemoradiation. This presentation is scheduled for 10:45 a.m. to noon PT in Hall F.

The participation of Roswell Park at the ASTRO Annual Meeting underscores the institution’s commitment to advancing cancer treatment through innovative research and collaborative efforts in the medical community. The insights gained from these studies may significantly influence treatment protocols and improve patient outcomes in lung and other cancers.